KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Honeywell International (HON) Payables (2016 - 2025)

Honeywell International has reported Payables over the past 17 years, most recently at $12.2 billion for Q4 2025.

  • Quarterly results put Payables at $12.2 billion for Q4 2025, up 17.66% from a year ago — trailing twelve months through Dec 2025 was $12.2 billion (up 17.66% YoY), and the annual figure for FY2025 was $12.2 billion, up 17.66%.
  • Payables for Q4 2025 was $12.2 billion at Honeywell International, down from $14.2 billion in the prior quarter.
  • Over the last five years, Payables for HON hit a ceiling of $14.2 billion in Q3 2025 and a floor of $8.3 billion in Q1 2024.
  • Median Payables over the past 5 years was $9.8 billion (2022), compared with a mean of $10.3 billion.
  • Biggest five-year swings in Payables: dropped 17.11% in 2024 and later skyrocketed 50.72% in 2025.
  • Honeywell International's Payables stood at $10.0 billion in 2021, then dropped by 9.77% to $9.0 billion in 2022, then dropped by 1.24% to $8.9 billion in 2023, then increased by 16.21% to $10.4 billion in 2024, then grew by 17.66% to $12.2 billion in 2025.
  • The last three reported values for Payables were $12.2 billion (Q4 2025), $14.2 billion (Q3 2025), and $13.4 billion (Q2 2025) per Business Quant data.